Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs
On August 3, Ocular Therapeutix (NASDAQ:OCUL) reported second-quarter 2026 financial results that read as much like a regulatory…
New Year’s Holiday, Jobless Claims, Pending Home Sales, Fed Minutes
Getty Investors will ring in 2026 after seeing major market indexes rise by more than double digits in…